How to appeal a Cigna treatment-resistant depression — rtms, spravato, ect denial

The framework that applies to your appeal

Federal law gives you the right to a full and fair internal appeal, then an external review by an independent third party.

Cigna-specific note: Sold its Medicaid Advantage book to HCSC in 2023. Express Scripts (PBM) is Cigna-owned. Frequent class-action litigation around mental health parity.

What Cigna's policy requires for treatment-resistant depression — rtms, spravato, ect

Cited policy: Cigna Medical Coverage Policy: Electroconvulsive Therapy

Severe MDD (with or without psychotic features), bipolar depression, catatonia, mania, or selected schizophrenia. Index acute course typically 6-12 sessions (RUL ultra-brief or bilateral). Continuation/maintenance ECT covered per CORE protocol after acute response. Anesthesia evaluation, EKG, labs required. Pregnancy / geriatric / medical-comorbid populations covered with informed consent.

How Cigna denies treatment-resistant depression — rtms, spravato, ect — and how to counter it

Where Cigna pushes back: 1) ECT is last-resort, requires multiple drug failures; 2) Maintenance ECT 'experimental'; 3) Unilateral ECT only — bilateral 'cognitively harmful'.

Counter-arguments that hold up: ECT FDA Class II reclassification Dec 2018 final rule — for MDD, bipolar depression, catatonia. APA Practice Guideline + AAN 2018 + ISEN — first-line for severe MDD with psychosis, catatonia, suicidality, geriatric MDD, pregnancy MDD. INTREPID Lisanby AJP 2017 — efficacy + safety. CORE Kellner Br J Psychiatry 2010 — continuation ECT vs pharmacotherapy. GUIDE Kellner J ECT 2016 — ultra-brief pulse RUL with comparable efficacy + reduced cognitive effects. Bilateral indicated for psychosis / catatonia / treatment-urgent presentations.

What Cigna typically denies for treatment-resistant depression — rtms, spravato, ect

Across Cigna's commercial and Medicare books, denials cluster around a small number of patterns. For treatment-resistant depression — rtms, spravato, ect, expect:

• Mental health parity violations
• Step therapy
• Specialty drug prior auth
• OON balance billing disputes

Treatments most often denied in this category

These are the treatment-resistant depression — rtms, spravato, ect treatments most often flagged for prior auth, step therapy, or medical necessity review:

• NeuroStar rTMS (10 Hz)
• Brainsway Deep TMS
• Magstim Horizon rTMS
• MagVenture rTMS
• iTBS (theta-burst)
• SAINT / SNT accelerated iTBS

How to submit the appeal to Cigna

1. Read the denial letter — note the exact denial reason code and the appeal deadline (180 days from the date on the letter).
2. Gather supporting documentation: physician letter of medical necessity, relevant clinical notes, peer-reviewed citations supporting the treatment for your indication, and the policy or coverage document Cigna cited in the denial.
3. File the appeal through Cigna's portal (members: https://my.cigna.com ; providers: https://cignaforhcp.cigna.com). Standard decision returns within 30 days; expedited urgent appeals return within 72 hours.
4. If denied again, request external review by an independent reviewer within 4 months of the final internal denial. In CT, the state insurance department coordinates external review for fully-insured plans; ERISA self-funded plans use a federal external review through DOL/EBSA.

Clinician or prior-auth team handling this on the practice side? See Cigna's prior-authorization criteria by drug: Cigna PA criteria on ApprovalHelp.